FDA Rejects Merck's Latest COX-2 Drug
The U.S. Food and Drug Administration has rejected Merck & Co.'s bid for approval of its painkiller and osteoarthritis treatment Arcoxia, a drug that is in the same class as Vioxx,...To view the full article, register now.
Already a subscriber? Click here to view full article